SoftBank-Backed Cancer Detector Guardant Said to Weigh U.S. IPO

(Bloomberg) -- Guardant Health Inc., a Silicon Valley cancer detection firm, is considering an initial public offering in the U.S., people with knowledge of the matter said.

Bloomberg Quint

Add BloombergQuint App to Home screen.